round button
Chat now

Middle East and Africa IVD Regulatory Affairs Outsourcing Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Middle East and Africa IVD Regulatory Affairs Outsourcing Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Mar 2022
  • MEA
  • 350 Pages
  • No of Tables: 142
  • No of Figures: 28

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 SERVICE TIMELINE CURVE

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, REGULATORY SCENARIO

4.1.1 THE U.S.

4.1.2 REGULATIONS IN EUROPE

4.1.3 REGULATIONS IN ASIA

4.1.3.1 CHINA

4.1.3.2 SOUTH KOREA

4.1.3.3 MALAYSIA

4.1.3.4 THAILAND

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES ACROSS THE REGION

5.1.2 TECHNOLOGICAL ADVANCEMENT IN DEVELOPING VARIOUS IN VITRO DIAGNOSTIC DEVICES

5.1.3 DEVELOPMENT OF PROJECT-BASED SUPPORT LEADS TO LONG TERM OUTSOURCING AGREEMENT AMONG ORGANIZATION

5.1.4 INCREASE IN PRODUCT REGISTRATION NUMBERS AND CLINICAL TRIAL APPROVALS ACROSS THE REGION

5.2 RESTRAINTS

5.2.1 STRINGENT REGULATIONS REGARDING MEDICAL DEVICES IN DIFFERENT REGIONS

5.2.2 HIGHER COST RELATED TO MAINTENANCE AND OUTSOURCING OF IVD

5.3 OPPORTUNITIES

5.3.1 RISE IN STRATEGIC ACQUISITION & PARTNERSHIP AMONG ORGANIZATION

5.3.2 EMERGENCE OF VARIOUS EFFICIENT TECHNOLOGICAL SERVICES AND STANDARDS

5.3.3 INCREASE IN R&D ACTIVITIES BY COMPANIES ACROSS THE REGION

5.4 CHALLENGES

5.4.1 LACK OF INFRASTRUCTURE IN HEALTHCARE SERVICE

5.4.2 SHORTAGE OF SKILLED PERSONNEL FOR HANDLING IN VITRO DIAGNOSTIC DEVICES

6 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE

6.1 OVERVIEW

6.2 REGULATORY WRITING & SUBMISSIONS

6.3 LEGAL REPRESENTATION

6.4 REGULATORY CONSULTING

6.5 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

6.6 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

6.7 DATA MANAGEMENT SERVICES

6.8 OTHERS

7 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION

7.1 OVERVIEW

7.2 CLINICAL CHEMISTRY AND IMMUNOASSAYS

7.3 INFECTIOUS DISEASES

7.3.1 VIROLOGY

7.3.2 MICROBIOLOGY AND MYCOLOGY

7.3.3 BACTERIOLOGY

7.3.4 SEPSIS

7.3.5 HEPATITIS B

7.3.6 HEPATITIS C

7.3.7 MALARIA

7.3.8 TUBERCULOSIS

7.3.9 SYPHILIS

7.3.10 HUMAN PAPILLOMAVIRUS (HPV) INFECTION

7.3.11 OTHERS

7.4 HAEMATOLOGY

7.5 DRUG TESTING/PHARMACOGENOMICS

7.6 PRECISION MEDICINE

7.7 DIABETES

7.8 BLOOD TRANSFUSION

7.9 CARDIOLOGY

7.1 POINT OF CARE

7.10.1 WAIVED TEST

7.10.2 AT HOME TESTS

7.11 ONCOLOGY

7.12 NEUROLOGY

7.13 HIV/AIDS

7.14 GENETIC TESTING

7.15 OTHERS

8 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS

8.1 OVERVIEW

8.2 CLASS I

8.3 CLASS III

8.4 CLASS II

9 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE

9.1 OVERVIEW

9.2 CLOUD

9.3 ON-PREMISES

10 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE

10.1 OVERVIEW

10.2 LARGE ENTERPRISES

10.3 SMALL & MEDIUM ENTERPRISES (SMES)

11 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE

11.1 OVERVIEW

11.2 CLINICAL

11.3 PRECLINICAL

11.4 PMA (POST MARKET AUTHORIZATION)

12 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER

12.1 OVERVIEW

12.2 MEDICAL DEVICE COMPANIES

12.2.1 BY ORGANIZATION SIZE

12.2.1.1 LARGE ENTERPRISES

12.2.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.2.2 BY SERVICE

12.2.2.1 REGULATORY WRITING & SUBMISSIONS

12.2.2.2 LEGAL REPRESENTATION

12.2.2.3 REGULATORY CONSULTING

12.2.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.2.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.2.2.6 DATA MANAGEMENT SERVICES

12.2.2.7 OTHERS

12.3 PHARMACEUTICAL COMPANIES

12.3.1 BY ORGANIZATION SIZE

12.3.1.1 LARGE ENTERPRISES

12.3.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.3.2 BY SERVICE

12.3.2.1 REGULATORY WRITING & SUBMISSIONS

12.3.2.2 LEGAL REPRESENTATION

12.3.2.3 REGULATORY CONSULTING

12.3.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.3.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.3.2.6 DATA MANAGEMENT SERVICES

12.3.2.7 OTHERS

12.4 BIOTECHNOLOGY COMPANIES

12.4.1 BY ORGANIZATION SIZE

12.4.1.1 LARGE ENTERPRISES

12.4.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.4.2 BY SERVICE

12.4.2.1 REGULATORY WRITING & SUBMISSIONS

12.4.2.2 LEGAL REPRESENTATION

12.4.2.3 REGULATORY CONSULTING

12.4.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.4.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.4.2.6 DATA MANAGEMENT SERVICES

12.4.2.7 OTHERS

12.5 OTHERS

13 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION

13.1 MIDDLE EAST & AFRICA

13.1.1 SOUTH AFRICA

13.1.2 SAUDI ARABIA

13.1.3 U.A.E

13.1.4 EGYPT

13.1.5 ISRAEL

13.1.6 REST OF MIDDLE EAST & AFRICA

14 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ICON PLC

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 MEDPACE

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 PAREXEL INTERNATIONAL CORPORATION

16.3.1 COMPANY SNAPSHOT

16.3.2 COMPANY SHARE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENTS

16.4 LABCORP DRUG DEVELOPMENT

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 PPD INC. (A SUBSIDIARY OF THERMOFISHER SCIENTIFIC INC.)

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENTS

16.6 CHARLES RIVER LABORATORIES

16.6.1 COMPANY SNAPSHOT

16.6.2 REVENUE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENTS

16.7 FREYR

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 ASSENT COMPLIANCE INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 ANDAMAN MEDICAL

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 ASIA ACTUAL

16.10.1 COMPANY SNAPSHOT

16.10.2 SERVICE PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 AXSOURCE

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 CRITERIUM, INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 DOR PHARMACEUTICAL SERVICES

16.13.1 COMPANY SNAPSHOT

16.13.2 SERVICE PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 EMERGO BY UL

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 GENPACT

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 GROUPE PRODUCTLIFE S.A.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENTS

16.17 LORENZ LIFE SCIENCES GROUP

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 MAKROCARE

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 MARACA INTERNATIONAL BVBA

16.19.1 COMPANY SNAPSHOT

16.19.2 SERVICE PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 MDICONSULTANTS, INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 PBC BIOMED

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 PROMEDICA INTERNATIONAL, A CALIFORNIA CORPORATION

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENT

16.23 PROPHARMA GROUP

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENTS

16.24 QSERVE

16.24.1 COMPANY SNAPSHOT

16.24.2 SERVICE PORTFOLIO

16.24.3 RECENT DEVELOPMENTS

16.25 REGULATORY COMPLIANCE ASSOCIATES INC.

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENT

16.26 RMQ+

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENT

16.27 SARACA SOLUTIONS PRIVATE LIMITED

16.27.1 COMPANY SNAPSHOT

16.27.2 PRODUCT PORTFOLIO

16.27.3 RECENT DEVELOPMENT

16.28 VCLS

16.28.1 COMPANY SNAPSHOT

16.28.2 PRODUCT PORTFOLIO

16.28.3 RECENT DEVELOPMENTS

16.29 WUXI APPTEC

16.29.1 COMPANY SNAPSHOT

16.29.2 REVENUE ANALYSIS

16.29.3 PRODUCT PORTFOLIO

16.29.4 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 2 MIDDLE EAST & AFRICA REGULATORY WRITING & SUBMISSIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 3 MIDDLE EAST & AFRICA LEGAL REPRESENTATION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 4 MIDDLE EAST & AFRICA REGULATORY CONSULTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 5 MIDDLE EAST & AFRICA REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 6 MIDDLE EAST & AFRICA CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 7 MIDDLE EAST & AFRICA DATA MANAGEMENT SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY MATERIAL, 2020-2029 (USD THOUSAND)

TABLE 8 MIDDLE EAST & AFRICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 9 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 10 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY AND IMMUNOASSAYS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 11 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION,2020-2029 (THOUSAND)

TABLE 12 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 13 MIDDLE EAST & AFRICA HAEMATOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 14 MIDDLE EAST & AFRICA DRUG TESTING/PHARMACOGENOMICS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 15 MIDDLE EAST & AFRICA PRECISION MEDICINE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 16 MIDDLE EAST & AFRICA DIABETES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 17 MIDDLE EAST & AFRICA BLOOD TRANSFUSION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 18 MIDDLE EAST & AFRICA CARDIOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 19 MIDDLE EAST & AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 20 MIDDLE EAST & AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 21 MIDDLE EAST & AFRICA ONCOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 22 MIDDLE EAST & AFRICA NEUROLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 23 MIDDLE EAST & AFRICA HIV/AIDS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 24 MIDDLE EAST & AFRICA GENETIC TESTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 25 MIDDLE EAST & AFRICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 26 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 27 MIDDLE EAST & AFRICA CLASS I IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 28 MIDDLE EAST & AFRICA CLASS III IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 29 MIDDLE EAST & AFRICA CLASS II IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 30 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 31 MIDDLE EAST & AFRICA CLOUD IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 32 MIDDLE EAST & AFRICA ON-PREMISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 33 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 34 MIDDLE EAST & AFRICA LARGE ENTERPRISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 35 MIDDLE EAST & AFRICA SMALL & MEDIUM ENTERPRISES (SMES) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 36 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 37 MIDDLE EAST & AFRICA CLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 38 MIDDLE EAST & AFRICA PRECLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 39 MIDDLE EAST & AFRICA PMA (POST MARKET AUTHORIZATION) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 40 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 41 MIDDLE EAST & AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 42 MIDDLE EAST & AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 43 MIDDLE EAST & AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 44 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 45 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 46 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 47 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 48 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 49 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 50 MIDDLE EAST & AFRICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 51 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)

TABLE 52 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 53 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 54 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 55 MIDDLE EAST AND AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 56 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 57 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 58 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 59 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 60 MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 61 MIDDLE EAST AND AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 62 MIDDLE EAST AND AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 63 MIDDLE EAST AND AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 64 MIDDLE EAST AND AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 65 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 66 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 67 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 68 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 69 SOUTH AFRICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 70 SOUTH AFRICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 71 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 72 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 73 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 74 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 75 SOUTH AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 76 SOUTH AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 77 SOUTH AFRICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 78 SOUTH AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 79 SOUTH AFRICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 80 SOUTH AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 81 SOUTH AFRICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 82 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 83 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 84 SAUDI ARABIA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 85 SAUDI ARABIA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 86 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 87 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 88 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 89 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 90 SAUDI ARABIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 91 SAUDI ARABIA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 92 SAUDI ARABIA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 93 SAUDI ARABIA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 94 SAUDI ARABIA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 95 SAUDI ARABIA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 96 SAUDI ARABIA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 97 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 98 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 99 U.A.E INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 100 U.A.E POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 101 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 102 U.A.E. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 103 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 104 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 105 U.A.E IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 106 U.A.E MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 107 U.A.E MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 108 U.A.E PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 109 U.A.E PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 110 U.A.E BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 111 U.A.E BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 112 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 113 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 114 EGYPT INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 115 EGYPT POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 116 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 117 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 118 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 119 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 120 EGYPT IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 121 EGYPT MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 122 EGYPT MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 123 EGYPT PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 124 EGYPT PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 125 EGYPT BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 126 EGYPT BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 127 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 128 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 129 ISRAEL INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 130 ISRAEL POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BYTYPE, 2020-2029 (USD THOUSAND)

TABLE 131 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 132 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 133 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 134 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 135 ISRAEL IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 136 ISRAEL MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 137 ISRAEL MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 138 ISRAEL PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 139 ISRAEL PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 140 ISRAEL BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 141 ISRAEL BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 142 REST OF MIDDLE EAST AND AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

List of Figure

FIGURE 1 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: END USER COVERAGE GRID

FIGURE 10 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 11 RISE IN THE PREVALENCE OF CHRONIC DISEASES ACROSS IS EXPECTED TO DRIVE MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN 2022 & 2029

FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE AND IS THE FASTEST GROWING REGION IN THE MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET

FIGURE 15 MULTIPLE CHRONIC CONDITIONS AMONG PEOPLE AGED 65 AND ABOVE IN EUROPEAN REGION (2017)

FIGURE 16 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE, 2021

FIGURE 17 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY INDICATION, 2021

FIGURE 18 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY CLASS, 2021

FIGURE 19 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY DEPLOYMENT MODE, 2021

FIGURE 20 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY ORGANIZATION SIZE, 2021

FIGURE 21 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY STAGE, 2021

FIGURE 22 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY END USER, 2021

FIGURE 23 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SNAPSHOT (2021)

FIGURE 24 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021)

FIGURE 25 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2022 & 2029)

FIGURE 26 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021 & 2029)

FIGURE 27 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE (2022-2029)

FIGURE 28 MIDDLE EAST & AFRICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY SHARE 2021 (%)

Frequently Asked Questions

The Middle East and Africa IVD Regulatory Affairs Outsourcing Market will be projected to grow at a CAGR of 11.6% during the forecast period of 2022 to 2029.
The Middle East and Africa IVD Regulatory Affairs Outsourcing Market will be projected USD 47,861.92 thousand during the forecast period of 2022 to 2029.
The major players operating in the report are IVD regulatory affairs outsourcing market are Freyr Solutions, PPD Inc. (A Subsidiary of Thremofisher Scientific Inc.), EMERGO, ICON, Parexel International Corporation, CRITERIUM, INC., Groupe ProductLife S.A., Labcorp Drug Development, WuXi AppTec, Genpact, Medpace, Dor Pharmaceutical Services, Qserve, among others.
The major factors driving the growth of the IVD regulatory affairs outsourcing market are the rise in the prevalence of chronic diseases across the region and technological advancement in various in vitro diagnostic devices.
a